296 related articles for article (PubMed ID: 11423572)
1. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.
Kang DH; Joly AH; Oh SW; Hugo C; Kerjaschki D; Gordon KL; Mazzali M; Jefferson JA; Hughes J; Madsen KM; Schreiner GF; Johnson RJ
J Am Soc Nephrol; 2001 Jul; 12(7):1434-1447. PubMed ID: 11423572
[TBL] [Abstract][Full Text] [Related]
2. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.
Kang DH; Anderson S; Kim YG; Mazzalli M; Suga S; Jefferson JA; Gordon KL; Oyama TT; Hughes J; Hugo C; Kerjaschki D; Schreiner GF; Johnson RJ
Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186
[TBL] [Abstract][Full Text] [Related]
3. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.
Kang DH; Hughes J; Mazzali M; Schreiner GF; Johnson RJ
J Am Soc Nephrol; 2001 Jul; 12(7):1448-1457. PubMed ID: 11423573
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide modulates vascular disease in the remnant kidney model.
Kang DH; Nakagawa T; Feng L; Johnson RJ
Am J Pathol; 2002 Jul; 161(1):239-48. PubMed ID: 12107108
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis.
Kang DH; Johnson RJ
Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):43-9. PubMed ID: 12496665
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.
Doll JA; Reiher FK; Crawford SE; Pins MR; Campbell SC; Bouck NP
Prostate; 2001 Dec; 49(4):293-305. PubMed ID: 11746276
[TBL] [Abstract][Full Text] [Related]
7. Kidney vasculogenesis and angiogenesis: role of vascular endothelial growth factor.
Del Porto F; Mariotti A; Ilardi M; Messina FR; Afeltra A; Amoroso A
Eur Rev Med Pharmacol Sci; 1999; 3(4):149-53. PubMed ID: 11073120
[TBL] [Abstract][Full Text] [Related]
8. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.
Kang DH; Yu ES; Yoon KI; Johnson R
Am J Pathol; 2004 Feb; 164(2):679-88. PubMed ID: 14742271
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis.
Zhang QX; Magovern CJ; Mack CA; Budenbender KT; Ko W; Rosengart TK
J Surg Res; 1997 Feb; 67(2):147-54. PubMed ID: 9073561
[TBL] [Abstract][Full Text] [Related]
10. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.
Spyridopoulos I; Luedemann C; Chen D; Kearney M; Chen D; Murohara T; Principe N; Isner JM; Losordo DW
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):901-6. PubMed ID: 12067896
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis.
Tomanek RJ; Sandra A; Zheng W; Brock T; Bjercke RJ; Holifield JS
Circ Res; 2001 Jun; 88(11):1135-41. PubMed ID: 11397779
[TBL] [Abstract][Full Text] [Related]
12. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice.
Mattot V; Moons L; Lupu F; Chernavvsky D; Gómez RA; Collen D; Carmeliet P
J Am Soc Nephrol; 2002 Jun; 13(6):1548-60. PubMed ID: 12039984
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
14. Role of the microvascular endothelium in progressive renal disease.
Kang DH; Kanellis J; Hugo C; Truong L; Anderson S; Kerjaschki D; Schreiner GF; Johnson RJ
J Am Soc Nephrol; 2002 Mar; 13(3):806-816. PubMed ID: 11856789
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 modulation on thrombospondin-1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstruction.
Xie XS; Liu HC; Wang FP; Zhang CL; Zuo C; Deng Y; Fan JM
Phytother Res; 2010 Nov; 24(11):1581-7. PubMed ID: 21031612
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
[TBL] [Abstract][Full Text] [Related]
17. VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures.
Kim BS; Chen J; Weinstein T; Noiri E; Goligorsky MS
J Am Soc Nephrol; 2002 Aug; 13(8):2027-36. PubMed ID: 12138133
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain.
Ment LR; Stewart WB; Fronc R; Seashore C; Mahooti S; Scaramuzzino D; Madri JA
Brain Res Dev Brain Res; 1997 May; 100(1):52-61. PubMed ID: 9174246
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
20. Molecular mediators of angiogenesis in bladder cancer.
Campbell SC; Volpert OV; Ivanovich M; Bouck NP
Cancer Res; 1998 Mar; 58(6):1298-304. PubMed ID: 9515819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
